Business Context and Reporting Period
This Form 8-K Current Report from Aldeyra Therapeutics, Inc. (ALDX) covers the event date of December 23, 2025. The filing addresses Item 5.02 regarding the departure of a senior officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It is a current report focused on personnel changes rather than financial performance.
Material Changes
The primary material change is the voluntary resignation of Stephen G. Machatha, Ph.D., as Chief Development Officer. Dr. Machatha's last day of employment is set for on or before March 31, 2026. The resignation is not attributed to any dispute regarding the Company's operations, policies, accounting practices, or financial reporting.
Management Commentary and Compensation Arrangements
Management entered into a Transition Agreement with Dr. Machatha to ensure a smooth handover of duties. Key terms include:
- Transition Period: Dr. Machatha will remain employed through the Separation Date, receiving his current base salary and participating in employee benefit plans.
- Equity Vesting: Outstanding stock options and restricted stock units will continue to vest according to their original terms.
- Severance/Bonus: A lump sum payment of $88,000 (50% of the potential 2025 bonus based on 110% of target) is payable upon execution of the agreement. An additional $88,000 is payable if Dr. Machatha executes a release of claims between the Separation Date and the following business day.
Investor Verification Checklist
- Verify the exact Separation Date (on or before March 31, 2026) and the status of the second $88,000 payment contingent on the release of claims.
- Review the full text of the Transition Agreement when filed as an exhibit to the Annual Report on Form 10-K.
- Monitor subsequent filings for the appointment of a new Chief Development Officer or interim leadership structure.
- Confirm that no other undisclosed disputes exist regarding financial reporting, as explicitly stated in the filing.